buy

Novo Nordisk A/S ADR buy Cantor Fitzgerald

Novo Nordisk A/S ADR

Start price

€121.00

/ 50%

Target price

20.03.25

Performance (%)

Price

Summary

This prediction is currently active. With a performance of , the BUY prediction by Cantor_Fitzgerald is trending in the wrong direction. Dividends of are taken into consideration when calculating the performance. This prediction currently runs until 20.03.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this prediction

Performance without dividends (%)

Name	1w	1m
Novo Nordisk A/S ADR
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by Cantor_Fitzgerald for this prediction

In the thread Novo Nordisk A/S ADR diskutieren

Prediction Buy

Perf. (%)

Target price 147.488

Change

Ends at

Novo Nordisk A/S (NYSE: NVO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $160.00 price target on the stock.

Ratings data for NVO provided by MarketBeat

Cantor Fitzgerald